Matsukura Norio, Yokomuro Shigeki, Yamada Sirikan, Tajiri Takashi, Sundo Trichak, Hadama Tohru, Kamiya Shigeru, Naito Zenya, Fox James G
First Department of Surgery, 2Department of Pathology II, Nippon Medical School, Bunkyo-ku, Tokyo 113-8603, Japan.
Jpn J Cancer Res. 2002 Jul;93(7):842-7. doi: 10.1111/j.1349-7006.2002.tb01327.x.
Japan and Thailand have high incidences of bile duct carcinoma and gallstones. The presence of Helicobacter bilis (H. bilis) detected by polymerase chain reaction (PCR) and 16S rRNA analysis in bile samples from Chileans with chronic cholecystitis was reported. The association between H. bilis in bile and biliary tract malignancies has not been investigated, and therefore the aim of this study is to determine whether malignant diseases of the biliary tract are associated with the presence of H. bilis in bile samples obtained from two high-risk populations. Bile samples from 45 Japanese and 40 Thai patients were subjected to PCR analysis using H. bilis-specific primers, and six of the H. bilis amplicons were sequenced. Thirteen out of 15 (87%) Japanese and 11 out of 14 (79%) Thai patients with bile duct or gallbladder cancer tested positive for the presence of H. bilis in their bile. Eight out of 16 (50%) Japanese and 10 out of 26 (38%) Thai patients with gallstone and / or cholecystitis tested positive for H. bilis. Only 4 out of 14 (29%) subjects without biliary disease tested positive for H. bilis among the Japanese. Bile duct and gallbladder cancer showed significantly higher positive rates for H. bilis than did the non-biliary diseases among the Japanese (P < 0.01) and the odds ratios for bile duct or gallbladder cancer with H. bilis in comparison with gallstone and / or cholecystitis were 6.50 (95%CI 1.09 - 38.63) in the Japanese and 5.86 (1.31 - 26.33) in the Thai patients. In conclusion, H. bilis infection in bile was associated with biliary tract and gallbladder cancers in two high risk populations, Japanese and Thai.
日本和泰国的胆管癌及胆结石发病率较高。有报告称,通过聚合酶链反应(PCR)和16S rRNA分析在智利慢性胆囊炎患者的胆汁样本中检测到了胆汁幽门螺杆菌(H. bilis)。胆汁中的H. bilis与胆道恶性肿瘤之间的关联尚未得到研究,因此本研究的目的是确定从两个高危人群获取的胆汁样本中,胆道恶性疾病是否与H. bilis的存在有关。对45名日本患者和40名泰国患者的胆汁样本使用H. bilis特异性引物进行PCR分析,并对6个H. bilis扩增子进行测序。胆管或胆囊癌的15名日本患者中有l3名(87%)、14名泰国患者中有11名(79%)胆汁中H. bilis检测呈阳性。胆结石和/或胆囊炎的16名日本患者中有8名(50%)、26名泰国患者中有10名(38%)H. bilis检测呈阳性。在日本,无胆道疾病的14名受试者中只有4名(29%)H. bilis检测呈阳性。在日本,胆管和胆囊癌患者的H. bilis阳性率显著高于非胆道疾病患者(P<0.01),日本胆管或胆囊癌患者与胆结石和/或胆囊炎患者相比,H. bilis感染的优势比为6.50(95%CI 1.09 - 38.63),泰国患者为5.86(1.31 - 26.33)。总之,在日本和泰国这两个高危人群中,胆汁中的H. bilis感染与胆道和胆囊癌有关。